Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond

Saved in:
Bibliographic Details
Published inContraception (Stoneham) Vol. 101; no. 6; pp. 361 - 366
Main Authors Raymond, Elizabeth G., Grossman, Daniel, Mark, Alice, Upadhyay, Ushma D., Dean, Gillian, Creinin, Mitchell D., Coplon, Leah, Perritt, Jamila, Atrio, Jessica M., Taylor, DeShawn, Gold, Marji
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2020
Subjects
Abortifacient Agents, Nonsteroidal - administration & dosage
Abortifacient Agents, Steroidal - administration & dosage
Abortifacient Agents, Steroidal - therapeutic use
Abortion
Abortion, Induced - methods
Adult
Coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
COVID-19
Female
Humans
Mifepristone
Mifepristone - administration & dosage
Mifepristone - therapeutic use
Misoprostol
Misoprostol - administration & dosage
Misoprostol - therapeutic use
Pandemic
Pandemics
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Practice Guidelines as Topic
Telehealth
Ultrasound
COVID-19
Telehealth
Mifepristone
Pandemic
Abortion
Misoprostol
Ultrasound
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0010-7824
1879-0518
DOI:10.1016/j.contraception.2020.04.005